System and method for suggesting insurance eligible genetic efficacy tests

A system for suggesting insurance eligible genetic based medicine efficacy tests to a healthcare provider, carrying out ordered one or ones of the suggested tests, and providing results therefrom, the system comprising:

• electronic health record (“EHR”) systems, each of which is a legacy system associated with a healthcare provider office;
• a laboratory information system (“LIS”) associated with a laboratory and in electronic communication with each of the EHR systems, wherein said LIS comprises one or more electronic storage devices and one or more processors;
• an efficacy database comprising data regarding medications known to have reduced or no efficacy in persons having particular genetic markers;
• a treatment protocol database comprising medications associated with diagnoses, wherein said medications are those likely to be prescribed to treat the associated diagnosis;
• a healthcare information exchange (“HIE”) interposed between the LIS and each of the EHR systems;
• one or more robots associated with the laboratory and in electronic communication with the LIS and comprising one or more electronic storage devices comprising software instructions, which when executed, configure one or more processors of the one or more robots to, following receipt of instructions from the LIS to perform ordered genetic testing, assemble a testing device to add, remove, block, and/or unblock wells of the testing device in accordance with the instructions received from the LIS;
• a genetic sequencing device associated with the laboratory and in electronic communication with the LIS, wherein said genetic sequencing device comprises one or more electronic storage devices comprising software instructions, which when executed, configure one or more processors of the genetic sequencing machine to, following receipt of the instructions from the LIS to perform ordered genetic testing, perform the ordered genetic testing in an automated fashion in accordance with the instructions received from the LIS on a sample of genetic material obtained from a genetic material gathering device and applied to the testing device and determine genetic markers contained within the sample of genetic material;
• and
• an eligibility database comprising insurance eligibility rules;
• wherein the one or more electronic storage devices of the LIS comprise software instructions, which when executed, configure the one or more processors of the LIS to:
• receive notification of a new data entry at a particular one of the EHR systems for a particular patient, and in response:
• query the particular EHR system to retrieve insurance information, treatment codes for all active medications, and diagnostic codes for each active diagnosis associated with the particular patient;
• query the treatment protocol database to retrieve associated medications for each of the retrieved diagnoses;
• treat the associated medications as active medications;
• query the eligibility database to retrieve insurance eligibly rules for a particular insurance policy of a particular insurance provider based on the retrieved insurance information;
• determine one or more genetic tests that are eligible for coverage under the particular policy of the particular insurance provider by applying the retrieved insurance eligibility rules to the retrieved treatment and diagnostic codes;
• cause, by electronic transmission of data from the LIS, generation, at the particular EHR system, of an electronic notification indicating eligibility for genetic efficacy testing and a proposed order form for each of the one or more eligible genetic tests which is electronically interactive;
• receive, from the particular EHR system, data indicating an agreed order for at least one of the eligible genetic tests of the proposed order form indicated by electronic interaction at the proposed order form, and in response:
• generate and transmit electronic, machine-readable instructions to perform the ordered genetic testing to the genetic sequencing device;
• receive data indicating genetic testing results comprising genetic markers for the particular patient from the genetic sequencing device for the ordered genetic testing, and in response:
• query the efficacy database to determine whether any active medications in the retrieved active medications are known to have reduced or no efficacy in persons having the same genetic markers as the particular patient;
• and
• instruct the particular EHR system to contraindicate each of the active medications for the particular patient known to have reduced or no efficacy in persons having the same genetic markers as the particular patient at an existing, legacy field which is designated for use other than storage of genetic efficacy test result data.

A method for suggesting insurance eligible pharmacogenetic efficacy tests to a healthcare provider, carrying out ordered testing, and providing results therefrom, the method comprising the steps of:

• electronically and automatically querying an EHR system to retrieve insurance information, an active medication, and a diagnosis associated with a particular patient;
• electronically and automatically querying an eligibility database to retrieve insurance eligibly rules for a particular insurance policy of a particular insurance provider based on the retrieved insurance information;
• electronically and automatically determining, at a laboratory information system (“LIS”), pharmacogenetic efficacy tests that are eligible for coverage under the particular policy of the particular insurance provider by applying the retrieved insurance eligibility rules to the retrieved active medication and diagnosis;
• electronically and automatically causing, by electronic data transmission from the LIS to the EHR system, an electronic notification indicating eligibility for genetic efficacy testing and a proposed order form for each of the one or more eligible pharmacogenetic efficacy tests which is electronically interactive;
• electronically receiving, at the LIS from the EHR system, data indicating an agreed order for one or more of the eligible pharmacogenetic efficacy tests of the proposed order as indicated by electronic indication at the proposed order form;
• electronically and automatically generating and transmitting, from the LIS, electronic, machine-readable instructions to one or more robots to assemble a testing device by adding, removing blocking, and/or unblocking wells of the testing device in accordance with the ordered tests and to a genetic sequencing machine to perform the order tests to determine genetic markers for the particular patient;
• assembling the testing device using the one or more robots in accordance with in accordance with the electronic, machine-readable instructions received from the LIS and in an automated fashion;
• performing the ordered tests at the genetic sequencing machine in accordance with the electronic, machine-readable instructions to perform the ordered tests and in an automated fashion;
• electronically receiving, at the LIS from the genetic sequencing machine, data indicating the genetic markers for the particular patient;
• electronically and automatically querying an efficacy database to identify at least one of the retrieved active medications as being known to have reduced or no efficacy in persons having the same genetic markers as the particular patient;
• and
• electronically and automatically transmitting electronic, machine-readable instructions to the EHR system, which is a legacy system, to electronically flag each of the identified active medication as an allergy at a legacy allergy field of the EHR system.